Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01191346 · ClinicalTrials.gov registry record
Radiation Planning Study for High Grade Brain Tumors
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 24
- Enrollment target
NCT01191346: Completed study, sponsored by University of Cincinnati.
NCT01191346 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01191346 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if a higher strength MRI procedure provides better images to use in planning radiation treatments for patients with brain tumors in the future.
Primary Outcome
To assess the difference in treatment volume for radiation planning in gliomas as calculated using 1.5T versus 3T magnets
Interventions
- OTHER 3T MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-03 |
What the finished NCT01191346 record still lists
NCT01191346 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 3T MRI is the first listed.
NCT01191346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01191346 about?
NCT01191346 is a clinical study titled "Radiation Planning Study for High Grade Brain Tumors". The purpose of this research study is to see if a higher strength MRI procedure provides better images to use in planning radiation treatments for patients with brain tumors in the future.
What is the current status of trial NCT01191346?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2010-06. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01191346?
The interventions under investigation include: 3T MRI (OTHER).
Who is sponsoring clinical trial NCT01191346?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia